Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Sionna Therapeutics, Inc. (SION) had Return on Equity of -5.37% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-18.07M |
|
-- |
|
-- |
|
$21.91M |
|
$-21.91M |
|
$3.84M |
|
$-18.07M |
|
$-18.07M |
|
$-18.07M |
|
$-18.07M |
|
$-18.07M |
|
$-18.07M |
|
$-21.91M |
|
$-22.93M |
|
44.12M |
|
44.12M |
|
$-0.41 |
|
$-0.41 |
|
| Balance Sheet Financials | |
$266.75M |
|
$2.25M |
|
$85.30M |
|
$352.05M |
|
$7.55M |
|
-- |
|
$8.07M |
|
$15.62M |
|
$336.43M |
|
$336.43M |
|
$336.43M |
|
44.13M |
|
| Cash Flow Statement Financials | |
$-34.44M |
|
$-164.44M |
|
$202.08M |
|
$38.75M |
|
$41.95M |
|
$3.20M |
|
$4.93M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
35.33 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-34.53M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-5.37% |
-5.37% |
|
-5.13% |
|
-5.37% |
|
$7.62 |
|
$-0.78 |
|
$-0.78 |
|